420
Participants
Start Date
December 31, 2007
Primary Completion Date
April 30, 2009
Study Completion Date
April 30, 2009
adalimumab
Pre-filled syringe. See arm for more detail
Placebo
Pre-filled syringe. See arm for more detail
adalimumab
Pre-filled syringe. See arm for more detail
Brisbane
Cairns
The Bronx
Smithtown
Duncansville
Bethlehem
Philadelphia
West Reading
Monroe
Charlotte
Hickory
Ashville
Charleston
Greenville
Atlanta
Orange Park
Vero Beach
Aventura
Tampa
Sarasota
Palm Harbor
Tuscaloosa
Huntsville
Nashville
Jackson
Lexington
Brighton
Glendale
Frankfurt
Chicago
Moline
Springfield
Wichita
Covington
Oklahoma City
Dallas
Houston
Houston
San Antonio
Wheat Ridge
München
Ogden
Paradise Valley
Santa Monica
Torrance
Long Beach
West Hills
Victorville
Hemet
Bend
Olympia
Passaic
Winnipeg
Winnipeg
Fredericton
St. John's
Lunenburg
Burlington
Hamilton
Hamilton
Kitchener
Newmarket
Ottawa
Saint Catherines
Sarnia
Windsor
Montreal
Québec
Saint-Eustache
Sainte-Foy
Bad Nauheim
Berlin
Buch
Freiburg im Breisgau
Würzburg
Zerbst
Caguas
Ponce
Metropolitan Borough of Wirral
Liverpool
Oxford
Bath
Cannock
Newcastle upon Tyne
Leeds
Huddersfield
Lead Sponsor
Abbott
INDUSTRY